152
Participants
Start Date
October 1, 2025
Primary Completion Date
March 31, 2027
Study Completion Date
May 31, 2027
Enhearten with EMI
Enhearten is a digital intervention that is designed to foster adherence to medications for addiction treatment (MAT) and treatment retention while considering the unique needs of pregnant and postpartum women, and recently it has been adapted to include features designed to decrease self-stigma among app-users
Waitlist Control Group
Participants will receive access to Enhearten with EMI following the trial.
RECRUITING
Washington University School of Medicine, St Louis
National Institute on Drug Abuse (NIDA)
NIH
Washington University School of Medicine
OTHER